4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-017794
Options or other derivatives
- SVP, Chief Regulatory Affairs acquired 70,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ruff Shamim · SVP, Chief Regulatory Affairs
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-03-05 | Grant or award : show line 1 in the form Stock option (right to buy) | +70,000 | $71.45 | 2028-03-05 | 70,000 | 70,000 | D |
Loading xslF345X03/doc4.xml…